Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737665) titled 'Efficacy of Melatonin Treatment on Sleep Quality Improvement in Inflammatory Bowel Disease Patients With Clinical Remission: A Randomized Double-Blind Placebo-Controlled Trial' on July 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Mahidol University
Condition:
IBD (Inflammatory Bowel Disease)
Intervention:
Drug: Melatonin ("Circadin")
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: April 1, 2025 ...